Buy Ipamorelin 5mg Research Peptide Online
Ipamorelin is a selective hexapeptide growth hormone secretagogue (GHS) designed for investigation of somatotropic axis regulation and growth hormone secretion mechanisms in preclinical research models. This pentapeptide amide (Aib-His-D-2-methylTrp-Ala-Trp-D-Phe-NH2) demonstrates selective activation of growth hormone secretion in animal models with minimal prolactin or cortisol elevation.
Ipamorelin Peptide Classification & Pharmacological Profile
Ipamorelin is a synthetic hexapeptide functioning as a selective growth hormone secretagogue receptor (GHSR) agonist. The D-amino acid substitutions (D-2-methylTryptophan and D-Phenylalanine) confer metabolic stability and proteolytic resistance in cellular systems. Unlike nonselective GHS agents, preclinical research demonstrates ipamorelin exhibits reduced prolactin and adrenocorticotropin hormone (ACTH) stimulation in animal studies, enabling selective investigation of isolated somatotropic axis responses.
Ipamorelin Research-Characterized Mechanism Documentation
Extensive peer-reviewed preclinical literature documents ipamorelin-mediated activation of ghrelin receptor (GHSR-1a) on anterior pituitary somatotrophs. Published studies indicate GHSR activation triggers intracellular calcium mobilization, membrane depolarization, and growth hormone granule secretion through calcium-dependent exocytosis mechanisms independent of classical hypothalamic-pituitary-axis gonadotropin-releasing hormone (GnRH) signaling.
Ipamorelin Peer-Reviewed Research Foundation
Foundational preclinical research by Blake et al. (1999) in Neuroendocrinology characterized ipamorelin’s selective somatotropic effects in porcine pituitary preparations and isolated somatotroph cell cultures. Subsequent research by Liu et al. (2008) in the Journal of Endocrinology documented growth hormone secretion kinetics and comparative cortisol independence in conscious animal models, establishing mechanistic selectivity profiles and receptor specificity parameters.
Ipamorelin 5mg Product Specifications & Technical Parameters
Form: Lyophilized powder (synthetic, high-purity) Molecular Formula: C46H58N12O5 Molecular Weight: 711.01 Da Quantity: 5mg per vial Storage Conditions: -20°C (frozen); unopened stability 24 months Reconstitution: Bacteriostatic water or sterile saline per vial Purity: >99% (HPLC verified); endotoxin <1 EU/μg
Ipamorelin Research Use Only Disclaimer
Restricted exclusively to preclinical research. Not for human consumption, medical use, or veterinary applications. All protocols must comply with institutional biosafety committee guidelines and applicable regulatory requirements.